FDA Enforcement Class II Ongoing

InPen App, CFN: MMT-8060 (iOS Users) and MMT-8061 (Android Users)

Recall: Z-2496-2025 · Reported September 10, 2025

Enforcement

Recall Number
Z-2496-2025
Event ID
97237
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Medtronic MiniMed, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
September 10, 2025
Initiation Date
June 16, 2025
Classification Date
September 2, 2025
Address
18000 Devonshire St, N/A, Northridge, CA, 91325-1219, United States

Description

InPen App, CFN: MMT-8060 (iOS Users) and MMT-8061 (Android Users)

Reason

Medtronic MiniMed, Inc. is recalling InPen App for iOS and Android users due to software design errors that could lead to a missed short-acting insulin dose reminder and a recommendation to correct a high glucose value. It does not impact insulin delivery, long-acting insulin dose reminders, or CGM alerts, and users can still use the pen itself to calculate a dose, deliver insulin, record the dose date/time, and view CGM data. This issue was identified during internal testing before release in the US but after release to OUS customers, no complaints or MDRs related to this recall have been reported. Use of the affected device may result hyperglycemia by failing to alert the user and delay treatment of diabetes.

Code Info

UDI-DI: 0763000B000122075 CFN/Software Version: MMT-8060/7.0.0, 7.1.0, 7.2.0 and 7.5.0 MMT-8061/7.0.0, 7.0.1, 7.1.0, 7.1.1, 7.2.0 and 7.5.0

Distribution

International distribution to the countries of Argentina, Australia, Austria, Belgium, Bermuda, Chile, Czech Republic, Denmark, Egypt, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Luxembourg, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Serbia, Singapore, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, United Kingdom.

Quantity

6816